REDWOOD CITY, Calif., Jan. 5, 2015 /PRNewswire/ -- Capnia, Inc. (NASDAQ: CAPN), focused on the development of novel diagnostics and therapeutics based on its proprietary technologies for precision metering of gas flow, today announced that Anish Bhatnagar, M.D., Chief Executive Officer, will present at OneMedForum 2015 on Tuesday, January 13th, 2015 at 12:10 PM PT in San Francisco. Dr. Bhatnagar will be providing a corporate presentation, as well as a business update since Capnia completed its initial public offering on November 18, 2014. The presentation can be viewed after January 13, 2015 on the Company's website at http://investors.capnia.com/events-and-presentations.
About Capnia Capnia, Inc. develops and commercializes novel diagnostics and therapeutics based on its proprietary technologies for precision metering of gas flow. Capnia's lead diagnostic product is CoSense®, which aids in the diagnosis of hemolysis, a dangerous condition in which red blood cells degrade rapidly. CoSense, based on the Sensalyze™ Technology Platform, is a portable, non-invasive device that rapidly and accurately measures carbon monoxide in exhaled breath. CoSense has 510(k) clearance from the FDA and was launched in the U.S. in October 2014. CoSense has also received CE Mark approval for sale in the European Union. Capnia's proprietary therapeutic technology comprises the use of nasal, non-inhaled carbon dioxide to treat symptoms of allergies as well as the trigeminally mediated pain conditions such cluster headache and migraine.
Capnia Contact: David O'Toole Chief Financial Officer Capnia, Inc. (650) 353-5146 firstname.lastname@example.org
SOURCE Capnia, Inc.